New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01 - Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to support new and innovative epidemiology research in heart, lung, blood, and/or sleep diseases, disorders, and/or phenotypes. Through this FOA, the National Heart, Lung, and Blood Institute (NHLBI) aims to establish a new epidemiology cohort of at least 2000 participants to stimulate research on a wide range of heart, lung, blood, and/or sleep research hypotheses.


  • Letter of Intent:¬†30 days prior to the application due date
  • Application Due Date(s):¬†June 5, 2018, June 5, 2020

PAR-18-577 Expiration Date June 6, 2020

Agency Website

Amount Description

As a guidance, application budgets should not exceed $1.948 million in direct costs in the first year of the project period, and should not exceed $3.896 million in direct costs in any subsequent year of the project period.

Application budgets should reflect the actual needs of the proposed project.

Funding Type





Medical - Basic Science
Medical - Clinical Science
Social Sciences

External Deadline

June 5, 2020